Christèle Aubry, Carole Kebbi-Beghdadi, Amanda Luraschi-Eggemann, Gino Cathomen, Danuta Cichocka, Alexander Sturm, Gilbert Greub, The Eradiamr Consortium
{"title":"纳米运动技术:研究大肠杆菌细胞新陈代谢的创新方法,可作为耐受性的潜在指标。","authors":"Christèle Aubry, Carole Kebbi-Beghdadi, Amanda Luraschi-Eggemann, Gino Cathomen, Danuta Cichocka, Alexander Sturm, Gilbert Greub, The Eradiamr Consortium","doi":"10.1099/jmm.0.001912","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> Antibiotic tolerance corresponds to the bacterial ability to survive a transient exposure to antibiotics and is often associated with treatment failure. Current methods of identifying tolerance based on bacterial growth are time-consuming. This study explores the use of a growth-independent method utilizing nanomotion technology to detect antibiotic-tolerant bacteria.<b>Hypothesis.</b> The nanomotion signal obtained from a nanomechanical sensor measures real-time metabolic activity and cellular processes and could provide valuable information about the tolerance of bacteria to antibiotics that cannot be detected by standard antibiotic susceptibility tests.<b>Aim.</b> The aim of this study is to investigate the potential of nanomotion technology to record antibiotic-tolerant bacteria.<b>Methodology.</b> We generated a slow-growing <i>Escherichia coli</i> strain by manipulating <i>mazF</i> expression levels and confirmed its viability by several standard methods. We subsequently measured its nanomotion and the nanomotion of the WT <i>E. coli</i> in the presence or absence of antibiotics. Supervised machine learning was employed to distinguish slow-growing from exponentially growing bacteria. Observations for bacterial nanomotions were confirmed by standard kill curves.<b>Results.</b> We distinguished slow-growing from exponentially growing bacteria using specific features from the nanomotion signal. Furthermore, the exposition of both growth phenotypes to polymyxin decreased the nanomotion signal indicating cell death. Similarly, when exponentially growing cells were exposed to ampicillin, an antibiotic whose efficacy depends on the growth rate, the nanomotion signal also decreased. In contrast, the nanomotion signal remained unchanged for slow-growing bacteria upon exposure to ampicillin. In addition, antibiotic exposure can cause bacterial elongation, in which the biomass of a cell increases without cell division. By overexpressing <i>sulA</i>, we mimicked antibiotic-induced elongation. Differences in the nanomotion signal were observed when comparing elongating and non-elongating phenotypes.<b>Conclusion.</b> This work shows that nanomotion signals entail information about the reaction to antibiotics that standard MIC-based antibiotic susceptibility tests cannot detect. In the future, nanomotion-based antibiotic tolerance tests could be developed for clinical use in chronic or relapsing infections.</p>","PeriodicalId":94093,"journal":{"name":"Journal of medical microbiology","volume":"73 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nanomotion technology: an innovative method to study cell metabolism in <i>Escherichia coli</i>, as a potential indicator for tolerance.\",\"authors\":\"Christèle Aubry, Carole Kebbi-Beghdadi, Amanda Luraschi-Eggemann, Gino Cathomen, Danuta Cichocka, Alexander Sturm, Gilbert Greub, The Eradiamr Consortium\",\"doi\":\"10.1099/jmm.0.001912\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction.</b> Antibiotic tolerance corresponds to the bacterial ability to survive a transient exposure to antibiotics and is often associated with treatment failure. Current methods of identifying tolerance based on bacterial growth are time-consuming. This study explores the use of a growth-independent method utilizing nanomotion technology to detect antibiotic-tolerant bacteria.<b>Hypothesis.</b> The nanomotion signal obtained from a nanomechanical sensor measures real-time metabolic activity and cellular processes and could provide valuable information about the tolerance of bacteria to antibiotics that cannot be detected by standard antibiotic susceptibility tests.<b>Aim.</b> The aim of this study is to investigate the potential of nanomotion technology to record antibiotic-tolerant bacteria.<b>Methodology.</b> We generated a slow-growing <i>Escherichia coli</i> strain by manipulating <i>mazF</i> expression levels and confirmed its viability by several standard methods. We subsequently measured its nanomotion and the nanomotion of the WT <i>E. coli</i> in the presence or absence of antibiotics. Supervised machine learning was employed to distinguish slow-growing from exponentially growing bacteria. Observations for bacterial nanomotions were confirmed by standard kill curves.<b>Results.</b> We distinguished slow-growing from exponentially growing bacteria using specific features from the nanomotion signal. Furthermore, the exposition of both growth phenotypes to polymyxin decreased the nanomotion signal indicating cell death. Similarly, when exponentially growing cells were exposed to ampicillin, an antibiotic whose efficacy depends on the growth rate, the nanomotion signal also decreased. In contrast, the nanomotion signal remained unchanged for slow-growing bacteria upon exposure to ampicillin. In addition, antibiotic exposure can cause bacterial elongation, in which the biomass of a cell increases without cell division. By overexpressing <i>sulA</i>, we mimicked antibiotic-induced elongation. Differences in the nanomotion signal were observed when comparing elongating and non-elongating phenotypes.<b>Conclusion.</b> This work shows that nanomotion signals entail information about the reaction to antibiotics that standard MIC-based antibiotic susceptibility tests cannot detect. In the future, nanomotion-based antibiotic tolerance tests could be developed for clinical use in chronic or relapsing infections.</p>\",\"PeriodicalId\":94093,\"journal\":{\"name\":\"Journal of medical microbiology\",\"volume\":\"73 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medical microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1099/jmm.0.001912\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1099/jmm.0.001912","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
引言抗生素耐受性是指细菌在短暂接触抗生素后的存活能力,通常与治疗失败有关。目前根据细菌生长来确定耐受性的方法非常耗时。本研究利用纳米运动技术探索了一种与生长无关的方法来检测抗生素耐受性细菌。从纳米机械传感器获得的纳米运动信号可测量实时代谢活动和细胞过程,并可提供标准抗生素敏感性测试无法检测到的细菌对抗生素耐受性的宝贵信息。本研究旨在探讨纳米运动技术记录抗生素耐受性细菌的潜力。我们通过调节 mazF 的表达水平生成了生长缓慢的大肠杆菌菌株,并通过几种标准方法确认了其生存能力。随后,我们测量了它的纳米运动和 WT 大肠杆菌在抗生素存在或不存在时的纳米运动。我们采用了有监督的机器学习来区分缓慢生长和指数生长的细菌。对细菌纳米运动的观察结果通过标准杀灭曲线进行了确认。我们利用纳米运动信号的特定特征区分了慢速生长和指数生长细菌。此外,将这两种生长表型暴露于多粘菌素会降低纳米运动信号,表明细胞死亡。同样,当指数生长型细胞暴露于氨苄青霉素(一种药效取决于生长速度的抗生素)时,纳米运动信号也会降低。相比之下,缓慢生长的细菌在接触氨苄青霉素后纳米运动信号保持不变。此外,暴露于抗生素可导致细菌伸长,即细胞的生物量在不分裂的情况下增加。通过过量表达 sulA,我们模拟了抗生素诱导的伸长。在比较伸长和非伸长表型时,观察到了纳米运动信号的差异。这项工作表明,纳米运动信号包含对抗生素的反应信息,而基于 MIC 的标准抗生素药敏试验无法检测到这些信息。未来,基于纳米运动的抗生素耐受性测试可用于慢性或复发性感染的临床治疗。
Nanomotion technology: an innovative method to study cell metabolism in Escherichia coli, as a potential indicator for tolerance.
Introduction. Antibiotic tolerance corresponds to the bacterial ability to survive a transient exposure to antibiotics and is often associated with treatment failure. Current methods of identifying tolerance based on bacterial growth are time-consuming. This study explores the use of a growth-independent method utilizing nanomotion technology to detect antibiotic-tolerant bacteria.Hypothesis. The nanomotion signal obtained from a nanomechanical sensor measures real-time metabolic activity and cellular processes and could provide valuable information about the tolerance of bacteria to antibiotics that cannot be detected by standard antibiotic susceptibility tests.Aim. The aim of this study is to investigate the potential of nanomotion technology to record antibiotic-tolerant bacteria.Methodology. We generated a slow-growing Escherichia coli strain by manipulating mazF expression levels and confirmed its viability by several standard methods. We subsequently measured its nanomotion and the nanomotion of the WT E. coli in the presence or absence of antibiotics. Supervised machine learning was employed to distinguish slow-growing from exponentially growing bacteria. Observations for bacterial nanomotions were confirmed by standard kill curves.Results. We distinguished slow-growing from exponentially growing bacteria using specific features from the nanomotion signal. Furthermore, the exposition of both growth phenotypes to polymyxin decreased the nanomotion signal indicating cell death. Similarly, when exponentially growing cells were exposed to ampicillin, an antibiotic whose efficacy depends on the growth rate, the nanomotion signal also decreased. In contrast, the nanomotion signal remained unchanged for slow-growing bacteria upon exposure to ampicillin. In addition, antibiotic exposure can cause bacterial elongation, in which the biomass of a cell increases without cell division. By overexpressing sulA, we mimicked antibiotic-induced elongation. Differences in the nanomotion signal were observed when comparing elongating and non-elongating phenotypes.Conclusion. This work shows that nanomotion signals entail information about the reaction to antibiotics that standard MIC-based antibiotic susceptibility tests cannot detect. In the future, nanomotion-based antibiotic tolerance tests could be developed for clinical use in chronic or relapsing infections.